Lyme disease is the leading vector-borne disease in North America and Europe, but it lacks single tests for early diagnosis. Here, authors develop a rapid and low-cost serologic test using synthetic peptides, a paper-based assay, and machine learning.
- Rajesh Ghosh
- Hyou-Arm Joung
- Dino Di Carlo
